BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38713052)

  • 21. Down-regulation of claudin-3 is associated with proliferative potential in early gastric cancers.
    Okugawa T; Oshima T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Matsumoto T; Miwa H
    Dig Dis Sci; 2012 Jun; 57(6):1562-7. PubMed ID: 22290341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.
    Wroblewski LE; Piazuelo MB; Chaturvedi R; Schumacher M; Aihara E; Feng R; Noto JM; Delgado A; Israel DA; Zavros Y; Montrose MH; Shroyer N; Correa P; Wilson KT; Peek RM
    Gut; 2015 May; 64(5):720-30. PubMed ID: 25123931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction.
    McCabe MJ; Tarulli GA; Laven-Law G; Matthiesson KL; Meachem SJ; McLachlan RI; Dinger ME; Stanton PG
    Hum Reprod; 2016 Apr; 31(4):875-86. PubMed ID: 26908839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
    Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
    Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers.
    Kim WK; Kwon Y; Jang M; Park M; Kim J; Cho S; Jang DG; Lee WB; Jung SH; Choi HJ; Min BS; Il Kim T; Hong SP; Paik YK; Kim H
    Sci Rep; 2019 Dec; 9(1):18440. PubMed ID: 31804558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.
    Rendón-Huerta E; Teresa F; Teresa GM; Xochitl GS; Georgina AF; Veronica ZZ; Montaño LF
    J Gastrointest Cancer; 2010 Mar; 41(1):52-9. PubMed ID: 19960275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.
    Voutsadakis IA; Digklia A
    Chin Clin Oncol; 2023 Feb; 12(1):2. PubMed ID: 36922358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues.
    Gao M; Li W; Wang H; Wang G
    Diagn Pathol; 2013 Dec; 8():205. PubMed ID: 24325792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinct expression patterns of claudin-2, -6, and -11 between human gastric neoplasms and adjacent non-neoplastic tissues.
    Lin Z; Zhang X; Liu Z; Liu Q; Wang L; Lu Y; Liu Y; Wang M; Yang M; Jin X; Quan C
    Diagn Pathol; 2013 Aug; 8():133. PubMed ID: 23919729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma.
    Tokuhara Y; Morinishi T; Matsunaga T; Ohsaki H; Kushida Y; Haba R; Hirakawa E
    Oncol Lett; 2015 Jul; 10(1):93-98. PubMed ID: 26170982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
    Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
    Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 35. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics.
    Voutsadakis IA
    Crit Rev Oncol Hematol; 2023 Jun; 186():103987. PubMed ID: 37059275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues.
    Wang H; Yang X
    Int J Clin Exp Pathol; 2015; 8(1):881-7. PubMed ID: 25755790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
    Li WT; Jeng YM; Yang CY
    Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study.
    Arpa G; Fassan M; Guerini C; Quaquarini E; Grillo F; Angerilli V; Guzzardo V; Lonardi S; Bergamo F; Lenti MV; Pedrazzoli P; Paulli M; Di Sabatino A; Vanoli A
    Virchows Arch; 2022 Dec; 481(6):853-863. PubMed ID: 35925388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Claudin-3 expression in gastric cancer].
    Danilova NV; Anikina KA; Oleynikova NA; Vychuzhanin DV; Malkov PG
    Arkh Patol; 2020; 82(2):5-11. PubMed ID: 32307433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.